DNA Synthesis Inhibitors Market Grows with Oncology and Virology Use
The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of cancer diagnoses, growing awareness,...
Category : Healthcare and Pharmaceutical
Novo Nordisk Resubmits Awiqli® for FDA Approval as Weekly Insulin Treatment
Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a...
Digital Floss Expands Partnerships to Support Live Dental Conferences
Digital Floss, a premier dental marketing and media agency, is proud to announce the expansion of its collaborative partnerships with leading dental conferences across the...
Locus Cell’s Zhubei Facility Signs Phase III Manufacturing MOU with Cambium
Locus Cell (TWSE: 6891), a leading regenerative medicine CDMO in Taiwan, announced it has signed a Memorandum of Understanding (MOU) with Australia-based Cambium Bio (ASX:...
Pier 88 & Theranica Get China Approval for Nerivio® REN Migraine Wearable
First and Only REN-Based Migraine Treatment Approved in China Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global...
Dr. Facemyer Launches Scholarship Program for Future Healthcare Leaders
Dr. Gregory Facemyer, a distinguished Preventative & Primary Care Family Physician, Immediate Past Lead Physician at NEOMED Health Care, former Partner/Owner of Ohio Family Health...
MedTech Investors Must Heed Dr. Chin’s Keynote on Spine Innovations
At the 32nd Annual Meeting of the Korean Spinal Neurosurgery Society in Seoul, KIC Ventures’ Founder and CEO Unveils a Global Vision for Transforming Spine...
HELIOS-B Study Shows Fewer GI Events with Vutrisiran in ATTR-CM
− Treatment with Vutrisiran Led to 37- 49% Lower Rates of Gastrointestinal Events, a Multisystem Manifestation of ATTR-CM, Across Multiple Treatment Groups, Compared to Placebo...
VITAL-HF Trial: Remote Digital Tool Improves Heart Failure Care
Story Health by Innovaccer, a digital care platform evaluated in the VITAL-HF trial, demonstrates safe and significant improvements in heart failure therapy optimization. Innovaccer Inc.,...
Varian Upgrades Halcyon Platform to Enhance Patient Experience
Varian, a Siemens Healthineers company, announced major advancements for its Halcyon treatment platform at the ASTRO 2025 Annual Meeting, including new, enhanced patient positioning, improved...
Veracyte Biomarker Predicts Hormone Therapy Benefit in Cancer
Findings from the first prospective validation trial for biomarker presented at ASTRO 2025 Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced that new data...
Virometix Completes Phase I Trial Enrollment for V-212 Vaccine
Virometix AG, a Swiss clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced that it has successfully completed enrollment in the Phase I clinical trial...
Genmab to Acquire Merus, Expanding Drug Pipeline and Strategy
Company Announcement Genmab A/S (Nasdaq: GMAB) and Merus N.V. (Nasdaq: MRUS) announced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire...
ENHERTU® Improves Disease-Free Survival in Breast Cancer Trial
Positive topline results from a planned interim analysis of the DESTINY-Breast05 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) demonstrated a highly statistically significant and clinically meaningful improvement in...
AutoNation Brings Hope and Comfort to Cancer Patients Nationwide
With more than $45 million raised – including $4 million last year, 36,000 Totes for Hope delivered, 30 Breast Cancer Research Foundation grants funded, and more than $2 million generated for...